SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

pharmacology chemotherapy

» Start this Course
(Practice similar questions for free)
Question:

Monoclonal antibodies

Author: Suzuki



Answer:

Monoclonal antibodies have become an active area of drug development for anticancer therapy and other non neoplastic diseases, because they are directed at specific targets and often have fewer adverse effects. They are created from B lymphocytes (from immunized mice or hamsters) fused with “immortal” B-lymphocyte tumor cells. The resulting hybrid cells can be individually cloned, and each clone will produce antibodies directed against a single antigen type. Recombinant technology has led to the creation of “humanized” antibodies that overcome the immunologic problems previously observed following administration of mouse (murine) antibodies.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Suzuki
Suzuki